Neoadjuvant chemoradiation therapy with capecitabine (CAP) plus oxaliplatin (OX) in rectal cancer: Final results of a phase II study

被引：1
|
作者：
Carlomagno, C. [1 ]
D'Armiento, F. [1 ]
Farella, A. [1 ]
Cannella, L. [1 ]
De Stefano, A. [1 ]
Colantuoni, M. [1 ]
Alfieri, S. [1 ]
Marra, M. [1 ]
Totaro, G. [1 ]
Pepe, S. [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4090
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Radiochemotherapy with Capecitabine and Oxaliplatin plus bevacizumab in locally advanced Rectal Cancer - Results of a phase II study
    Dellas, K.
    Hoehler, T.
    Riesenbeck, D.
    Reese, T.
    Wuerschtnidt, F.
    Engel, E.
    Roedel, C.
    Wagner, W.
    Richter, M.
    Dunst, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 51 - 51
  • [2] Neoadjuvant chemoradiotherapy in rectal cancer patients (pt) with oxaliplatin (Ox) and capecitabine (Cp): Results of a phase II trial
    Gasent Blesa, J.
    Alberola Candel, V.
    Juan, O.
    Provencio Pulla, M.
    Giner Marco, V.
    Gravalos, C.
    Fernandez, I.
    Llorca, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer
    Zhao, Lin
    Bai, Chunmei
    Shao, Yajuan
    Guan, Mei
    Jia, Ning
    Xiao, Yi
    Qiu, Huizhong
    Zhang, Fuquan
    Yang, Ti
    Zhong, Guangxi
    Chen, Shuchang
    CANCER LETTERS, 2011, 310 (02) : 134 - 139
  • [4] A phase I and biological correlates study of capecitabine (CAP) plus oxaliplatin (OX) plus radiation therapy (RT) in locally advanced rectal cancer (LARC).
    Fakih, MG
    Rajput, A
    Yang, GY
    Pendyala, L
    Toth, K
    Lawrence, DD
    Smith, JL
    Soehnlein, NA
    Flaherty, L
    Rustum, YM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 279S - 279S
  • [5] S0713: A phase II study of cetuximab (CET) added to induction chemotherapy (ICT) of oxaliplatin (OX) and capecitabine (CAP), followed by neoadjuvant chemoradiation (NACR) for locally advanced rectal cancer (LARC).
    Leichman, Cynthia G.
    McDonough, Shannon L.
    Smalley, Stephen R.
    Billingsley, Kevin G.
    Lenz, Heinz-Josef
    Beldner, Matthew A.
    Hezel, Aram F.
    Velasco, Mario R.
    Guthrie, Katherine A.
    Blanke, Charles David
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
    Yu, Xin
    Wang, Qiao-xuan
    Xiao, Wei-wei
    Chang, Hui
    Zeng, Zhi-fan
    Lu, Zhen-hai
    Wu, Xiao-jun
    Chen, Gong
    Pan, Zhi-zhong
    Wan, De-sen
    Ding, Pei-rong
    Gao, Yuan-hong
    CANCER COMMUNICATIONS, 2018, 38
  • [7] A phase ii study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer
    Bendell, J.
    Fernando, N.
    Morse, M.
    Blobe, G.
    Yu, D.
    Sutton, L.
    Vaccaro, G.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    ANNALS OF ONCOLOGY, 2006, 17 : 67 - 67
  • [8] Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
    Glynne-Jones, R
    Sebag-Montefiore, D
    Samuel, L
    Falk, S
    Maughan, T
    McDonald, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 252S - 252S
  • [9] Neoadjuvant chemoradiation in locally advanced rectal cancer: Results of a phase II study
    P. Delrio
    A. Avallone
    C. Guida
    P. Marone
    A. Petrillo
    F. Tatangelo
    M. Di Marzo
    D. Scala
    V. Parisi
    Annals of Surgical Oncology, 2004, 11 : S115 - S115
  • [10] Neoadjuvant chemoradiation in locally advanced rectal cancer: Results of a phase II study
    Delrio, P
    Avallone, A
    Guida, C
    Marone, P
    Petrillo, A
    Tatangelo, F
    Di Marzo, M
    Scala, D
    Parisi, V
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S115 - S115
12345